FBRX vs KIM · $360.2M cap vs P/E 27, rev $1.11B
Forte Biosciences Inc (FBRX) versus Kimco Realty Corporation (KIM) — a side-by-side from cached financials, not a winner call.
Forte Biosciences Inc (FBRX) is a biotechnology company listed on NASDAQ.
Kimco Realty Corporation (KIM) is a reit - retail company listed on US.
FBRX does not have a complete income-statement cache yet.
Latest reported KIM revenue for 2026-06-30 was $1.11B. Net income was $318.2M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
FBRX currently screens at market cap $360.2M. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
Not investment advice. Open the FBRX and KIM stock pages for the full models.
Not investment advice.